Effect of omapatrilat on the aging process of the normal rat

Cellular and Molecular Biology

Volumn 51, Issue 6, 2005, Pages 557-564

  Basso, N ^a   Paglia, N ^a   Cini, R ^a   Inserra, F ^a   Terragno, N A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aging; Brain; Cardiovascular system; Kidney; Mitochondria; Nitric oxide synthase; Oxidative stress; Renin angiotensin system

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALINASE INHIBITOR; NITRIC OXIDE SYNTHASE; OMAPATRILAT;

AGED; AGING; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; BRAIN FUNCTION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHEMICAL ANALYSIS; CHRONIC DRUG ADMINISTRATION; COGNITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOLOGY; INFLAMMATION; KIDNEY FUNCTION; METABOLISM; NEUROPROTECTION; NONHUMAN; RAT; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENILITY; VASOCONSTRICTION; WEANING;

AGING; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR SYSTEM; COGNITION; INFLAMMATION; KIDNEY; NITRIC OXIDE SYNTHASE; PROTEASE INHIBITORS; PYRIDINES; RATS; RENIN-ANGIOTENSIN SYSTEM; THIAZEPINES; VASOCONSTRICTION; VASODILATION;

ANIMALIA;

EID: 28144433158     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T663     Document Type: Review

References (67)

1. Abboud, H.E., Resident glomerular cells in glomerular injury: mesangial cells. Semin. Nephrol. 1991, 11: 304-311.
2. Albiston, A.L., Mustafa, T., McDowall, S.G., Mendelsohn, F.A., Lee, J. and Chai, S.Y., AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement. Trends Endocrinol. Metabol. 2003, 14: 72-77.
3. Anderson, S., Meyer, T.W., Renneke, H.G. and Brenner, B.M., Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 1985, 76: 612-619.
4. Anversa, P., Palackal, T., Sonnenblick, E.H., Olivetti, G., Meggs, L.G. and Capasso, J.M., Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ. Res. 1990, 67: 871-885.
5. Assayag, P., Charlemagne, D., De Leiris, J., Boucher, F., Valere, P.E., Lortet, S., Swynghedauw, B. and Besse, S., Senescent heart compared with pressure overload-induced hypertrophy. Hypertension 1997, 29: 15-21.
6. Basso, N., Terragno, N., Paglia, N., Stella, I. and Inserra, F., Effect of chronic omapatrilat treatment on cardiac alterations due to aging in normal rats. J. Hypertens. 2004, 22: S41.
7. Basso, N., Terragno, N., Paglia, N., Stella, I., Inserra, F. and Ferder, L., Effect of chronic omapatrilat treatment on renal alterations due to aging in normal rats. J. Hypertens. 2004, 22: S152.
8. Barja, G., Free radicals and aging. Trends Neurosci. 2004, 27: 595-600.
9. Benetos, A., Laurent, S., Hoeks, A.P., Boutouyrie, P.H. and Safar, M.E., Arterial alterations with aging and high blood pressure. Arterioscler. Thromb. 1993, 13: 90-97.
10. Bliss, T.V.P. and Collingridge, G.L., A synaptic model of memory long-term potentiation in the hippocampus. Nature 1993, 361: 31-39.
11. Braszko, J.J., Kulakowska, A. and Wisniewski, K., Angiotensin II and its 3-7 fragment improves recognition but not spatial memory in rats. Brain Res. Bull. 1995, 37: 627-631.
12. Bunneman, B., Fuxe, K. and Ganten, D., The renin-angiotensin system in the brain: an update 1993. Regul. Pept. 1993, 46: 487-509.
13. Burrell, L.M., Droogh, J., Man in't Veld, O., Rockell, M.D., Farina, N.K. and Johnston, C.I., Antihypertensive and antihypertrophic effects of omapatrilat in SHR. Am. J. Hypertens. 2000, 13: 1110-1116.
14. Cain, D.P., Testing the NMDA, long-term potentiation, and cholinergic hypothesis of spatial learning. Neurosci. Biobeh. Rev. 1998, 22: 181-193.
15. Cavanagh, E.M.V. de, Piotrkowski, B., Basso, N., Stella, I., Inserra, F., Ferder L. and Fraga, C., Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J. 2003, 17: 1096-1098.
16. Chen, H.H., Lainchbury, J.G., Matsuda, Y., Harty, G.J. and Burnett, J.C. Jr., Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure. Hypertension 2001, 38: 187-191.
17. Chou, T.C., Yen, M.H., Li, C.Y. and Ding, Y.A., Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998, 31: 643-648.
18. Cohen, D.S., Mathis, J.E., Dotson, R.A., Graybill, S.R. and Wosu, N.J., Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure. J. Cardiovasc. Pharmacol. 1998, 32: 87-95.
19. Collister, J.P., Hornfeldt, B.J. and Osborn, J.W., Hypotensive response to losartan in normal rats. Role of Ang II and the area postrema. Hypertension 1996, 27: 598-606.
20. Colombo, P.J. and Gallagher, M., Individual differences in spatial memory and striatal ChAT activity among young and aged rats. Neurobiol. Learn. Mem. 1998, 70: 314-327.
21. Costa, L.E., La-Padula, P., Lores-Arnaiz, S., D'Amico, G., Boveris, A., Kurnjek M.L. and Basso, N., Long-term angiotensin II inhibition increases mitochondrial nitric oxide synthase and not antioxidant enzyme activities in rat heart. J. Hypertens. 2002, 20: 2487-2494.
22. Dong, Y., Zhou, H., Shaffer, E., Atamas, N., Liao, W.C. and Wei, C., The cardiovascular actions of omapatrilat in spontaneously hypertensive rats. Curr. Hypertens. Rep. 2001, 3(Suppl .2): S1-S5.
23. Dumoulin, M.J., Adam, A., Rouleau, J.L. and Lamontagne, D., Comparison of a vasopeptidase inhibitor with neutral endopeptidase and converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed. J. Cardiovasc. Pharmacol. 2001, 37: 359-366.
24. Ferder, L., Inserra, F., Romano, L., Ercole, L. and Pszenny, V., Decreased glomerulosclerosis in aging by angiotensin-converting anzyme inhibitors. J. Am. Soc. Nephrol. 1994, 5: 1147-1152.
25. Ferder, L.F., Inserra, F. and Basso, N., Advances in our understanding of aging: role of the renin-angiotensin system. Curr. Opin. Pharmacol. 2002, 2: 189-194.
26. Fine, L.G., Biology of renal hypertrophy. Kidney Int. 1986, 29: 619-634.
27. Flordellis, C.S., Goumenos, D., Kourounis, G., Tsementzis, S.A., Paris, H. and Vlachojiannis, J., The shift in the "Paradigm" of the pharmacology of hypertension. Curr. Top. Med. Chem. 2004, 4: 487-498.
28. Gaballa, M.A., Jacob, C.T., Raya, T.E., Liu, J., Simon, B. and Goldman, S., Large artery remodeling during aging. Biaxial passive and active stiffness. Hypertension 1998, 32: 437-443.
29. Gilbert, R.E., Kelly, D.J. and Atkins, R.C., Novel approaches to the treatment of progressive renal disease. Curr. Opin. Pharmacol. 2001, 1: 183-189.
30. González Bosc, L.V., Kurnjek, M.L., Müller, A. and Basso, N., Effect of chronic angiotensin ii inhibition on the cardiovascular system of the normal rat. Am. J. Hypertens. 2000, 13: 1301-1307.
31. González Bosc, L.V., Kurnjek, M.L., Müller, A., Terragno, N.A. and Basso, N., Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging. J. Hypertens. 2001, 19: 1403-1409.
32. Heudes, D., Michel, O., Chevalier, J., Scalbert, E., Ezan, E., Bariety, J., Zimmerman, A. and Corman, B., Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. Am. J. Physiol. 1994, 266: R1038-R1051.
33. Hirawa, N., Uehara, Y., Kawabata, Y., Numabe, A., Tomoko, G., Toshio, I., Suzuki, T., Goto, A., Toyo-oka, T. and Omata, M., Longterm inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 1999, 34: 496-502.
34. Hostetter, T.H., Olson, J.L., Renneke, H.G., Venkatachalam, M.A. and Brenner, B.M., Hyperfiltration in remnant nephrons. A potentially adverse response to renal ablation. Am. J. Physiol. 1981, 241: F85-F93.
35. Inserra, F., Romano, L., Ercole, L. and Cavanagh, E.M. de., Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension 1996, 25: 437-442.
36. Inserra, F., Stella, I., Kurnjek, M.L., Terragno, N., Paglia, N., Basso, N. and Ferder, L., Losartan and enalapril protect against age related kidney lesions in normal rats treated from 12 to 18 months of age. J. Am. Soc. Nephrol. 2001, 12: 679A.
37. Kato, S., Luyckx, V.A., Ots, M., Lee, K.W., Ziai, F., Troy, J.L., Brenner, B.M. and MacKenzie, H.S., Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int. 1999, 56: 1037.
38. Keeley, F.W., Elmoselhi, A. and Leenen, F.H.H., Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am. J. Physiol. 1992, 262: H1013-H1021.
39. Koller, M., Krause, H.P., Hoffmeister, F. and Ganten, D., Endogenous brain angiotensin II disrupts passive avoidance behavior in rats. Neurosci. Lett. 1979, 14: 71-75.
40. Korf, S.C., White, L.R., Scheltens, P. and Launer, L.J., Midlife blood pressure and the risk of hippocampal atrophy. Hypertension 2004, 44: 29-34.
41. Küng, C.F. and Lüscher, T.F., Different mechanisms of endothelial disfunction with aging and hypertension in rat aorta. Hypertension 1995, 25: 194-200.
42. Lapointe, N. and Rouleau, J.L. Cardioprotective effects of vasopeptidase inhibitors. Can. J. Cardiol. 2002, 18: 415-420.
43. Lind, R., Swanson, L.W. and Ganten, D., Organization of angiotensin II immuno-reactive cells and fibers in the rat central nervous system. Neuroendocrinology 1985, 40: 2-24.
44. López, J.J., Paglia, N., Capani, F., Coirini, H. and Basso, N., Participación del óxido nítrico en el efecto protector del OMA sobre el comportamiento de la rata añosa normal. Medicina 2003, 63: 563.
45. Manin, C.V., Meyer, D.M. and Redfield, M.M., Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension. Hypertension 2002, 40: 528-534.
46. Michel, J.B., Azizi, M., Salzmann, J.L., Levy, B. and Menard, J., Effect of vasodilators on the structure of the aorta in normotensive aging rats. J. Hypertens. 1987, 5: S165-S168.
47. Michel, J.B., Salzmann, J.L., Cerol, M., Dussaule, J.C., Azizi, M., Corman, B., Camilleri, J.P. and Corvol, P., Effect of converting enzyme inhibition in hypertensive and normotensive rats. Am. J. Med. 1988, 84: 12-21.
48. Mifsud, S.A., Burrell, L.M., Kubota, E., Jaworski, K., Cooper, M.E. and Wilkinson-Berka, J.L., Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN2) 27 rats. Clin. Exp. Hypertens. 2004, 26: 69-80.
49. Millette, E., Demeilliers, B., Wu, R., Laplante, M.A., El Midaoui, A., Morea Lamontagne, D. and de Champlain, J., Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension. J. Hypertens. 2003, 21: 125-135.
50. Mitchell, G.F., Izzo, J.L. Jr., Lacourciere, Y., Ouellet, J.P., Neutel, J., Qian, C., Kerwin, L.J., Block, A.J. and Pfeffer, M.A., Omapatrilat reduces blood pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduits hemodynamics of omapatrilat international research study., Circulation 2002, 105: 2955-2961.
51. Morgan, J.M. and Routtenberg, A., Angiotensin injected into the neostriatum after learning disrupts retention performance. Science 1977, 196: 87-89.
52. Noda, Y., Yamada, K. and Nabeshima, T., Role of nitric oxide in the effect of aging on spatial memory in rats. Behav. Brain Res. 1997, 83: 153-158.
53. Norman, J.T., The role of angiotensin II in renal growth. Renal Physiol. Biochem. 1991, 14: 175-185.
54. Phillips, M.I., Functions of angiotensin II in the central nervous system. Annu. Rev. Physiol. 1987, 49: 413-435.
55. Pu, Q. and Schiffrin, E.L., Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 2001, 14: 1067-1072.
56. Quaschning, T., d'Uscio, L.V., Shaw, S. and Luscher, T.F., Vasopeptidase inhibition exhibits endothelial protection in salt induced hypertension. Hypertension 2001, 37: 1108-1113.
57. Rovin, B.H. and Phan, L.T., Chemotactics factors and renal inflammation. Am. J. Kidney Dis. 1998, 31: 1065.
58. Schäfera, S., Linza, W., Bubeb, A., Gerlc, M., Hubera, J., Kürzeld, G.U., Bleicha, M., Schmidtsb, H.-L., Buscha, A.E. and Rüttena, H., Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovasc. Res. 2003, 60: 447-454.
59. Stemmelin, J., Cassel, J.C., Will, B. and Kelche, C., Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment. Behav. Brain Res. 1999, 98: 53-66.
60. Sugaya, K., Greene, R., Personett, D., Robbins, M., Kent, C., Bryan, D., Skiba, E., Gallagher, M. and McKinney, M., Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline. Neurobiol. Aging 1998, 19: 351-361.
61. Tikkanen, T., Tikkanen, I., Rockell, M.D., Allen, T.J., Johnston, C.I., Cooper, M.E. and Burrell, L.M., Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus. Hypertension 1998, 32: 778-785.
62. Touyz, R.M., Reactive oxygen species, vascular oxidative stress and redox signaling in hypertension. Hypertension 2004, 44: 248-252.
63. Unger, T., Chung, O., Csikos, T., Culman, J., Gallinat, S., Gohlke, P., Hohle, S., Meffert, S., Stoll, M., Stroth, U. and Zhu, Y.Z., Angiotensin receptors. J. Hypertens. 1996, 14(Suppl. 5): S95-S103.
64. Wayner, M.J., Armstrong, D.I., Polan-Curtain, J.L. and Denny, A.B., Ethanol and diazepam inhibition of hippocampal LTP is mediated by angiotensin II and AT1 receptors. Peptides 1993, 14: 441-444.
65. Weber, M.A., Vasopeptidase inhibitors. Lancet 2001, 358(9292): 1525-1532.
66. Wright, J.W. and Harding, J.W., Brain angiotensin receptor subtypes in the control of physiological and behavioral response. Neurosci. Biobeh. Rev. 1994, 18: 21-53.
67. Yamada, K., Noda, Y., Komori, Y., Sugihara, H., Hasegawa, T. and Nabeshima, T., Reduction in the number of NADPH-diaphorasepositive cells in the cerebral cortex and striatum in aged rats. Neurosci. Res. 1996, 24: 393-402.